Please write a half-page or a little longer double-spaced high level concise masters level summary of (key points including key leadership points of what he said about leadership and how to apply it) from the R'Kes Starling Interview
**Please utilize the following YouTube videos which is a requirement of the paper**
**This is a synopsis of the interview**
R'Kes Starling, RPh, MPA, CEO and Founder of Reveles Clinical Services, has over 18 years providing high-touch pharmacy services, clinical reach operations, specialty drug distribution, and clinical management to patients with rare and complex diseases such as Chronic Kidney disease, Cancer, Hemophilia, and Cystic Fibrosis. Prior to founding Reveles, R'Kes headed up the Specialty Pharmacy and Clinical Research Service businesses at McKesson, which comprised of two separate business units of an oncology-focused specialty pharmacy and the "central depot" that provides investigational product distribution, accountability, and storage for the US Oncology Research Network. R'Kes oversaw a multi-disciplinary clinical research team involved in over 130 active oncology-focused clinical trials and was responsible for delivering over 50,000 annual shipments of investigational products, laboratory kits, and clinical supplies to the US Oncology network sites across the United States.
Prior to McKesson, as the Vice President of Operations, he previously oversaw eight Home Infusion specialty pharmacies in six states with Coram CVS Specialty Infusion Services, which has translated into R'Kes having in-depth experience and knowledge of providing direct-to-patient care for thousands of patients on commercialized medications with complex and rare diseases in their homes. Prior to Coram, R'Kes held various management roles with DaVita, Inc., a Fortune 500 Dialysis services provider. Before the dialysis industry, R'Kes has worked in retail pharmacy operations management at Wal-Mart, Sam's Club, and Target Stores. Additionally, R'Kes have consulted and worked collaboratively with over 38 biopharmaceutical companies on pre-launch to commercialization development, launch strategies, and patient access programs for new specialty pharmaceutical therapies. R'Kes received his Bachelor of Science in Pharmacy from Purdue University and his Executive MBA from Kellogg School of Management, Northwestern University.